Human interleukin 6 is a direct promoter of maturation of megakaryocytes in vitro
- PMID: 2788282
- PMCID: PMC297749
- DOI: 10.1073/pnas.86.15.5953
Human interleukin 6 is a direct promoter of maturation of megakaryocytes in vitro
Abstract
The response of cells of the murine megakaryocytic lineage to human interleukin 6 (IL-6) was assessed in serum-depleted cultures using a variety of biological assays. IL-6 alone had no influence on megakaryocytic colony formation but augmented the numbers of these colonies induced by the multipotent colony-stimulating factor interleukin 3. However, in liquid marrow cultures, IL-6 alone promoted marked increments in megakaryocytic size and the activity of acetyl-cholinesterase, a marker enzyme of the lineage. Moreover, IL-6 induced a significant shift toward higher ploidy classes when megakaryocytic DNA was quantitated by flow cytometry. To determine whether the influence of IL-6 on megakaryocytic maturation was direct, the factor was added to cultures of single megakaryocytes isolated from megakaryocytic colonies. Fifty-four percent of these cells increased in size compared with 19% of those grown without IL-6. The data show that human IL-6 is a potent direct-acting growth factor for murine megakaryocytes with activity promoting maturation of that lineage.
Similar articles
-
Interleukin-12 enhances interleukin-3 dependent multilineage hematopoietic colony formation stimulated by interleukin-11 or steel factor.Leukemia. 1993 Sep;7(9):1374-80. Leukemia. 1993. PMID: 7690439
-
Interleukin 6 is a differentiation factor for human megakaryocytes in vitro.Eur J Immunol. 1990 Sep;20(9):1927-31. doi: 10.1002/eji.1830200909. Eur J Immunol. 1990. PMID: 2209699
-
Stem cell factor enhances proliferation, but not maturation, of murine megakaryocytic progenitors in serum-free culture.Blood. 1992 Oct 1;80(7):1743-9. Blood. 1992. PMID: 1382702
-
Megakaryocytic cells.Bibl Haematol. 1984;(48):131-209. doi: 10.1159/000408406. Bibl Haematol. 1984. PMID: 6398061 Review. No abstract available.
-
Regulation of hemopoietic cell development by interleukins 4, 5 and 6.Immunol Res. 1989;8(3):215-25. doi: 10.1007/BF02918146. Immunol Res. 1989. PMID: 2664035 Review. No abstract available.
Cited by
-
The paradigm of IL-6: from basic science to medicine.Arthritis Res. 2002;4 Suppl 3(Suppl 3):S233-42. doi: 10.1186/ar565. Epub 2002 May 9. Arthritis Res. 2002. PMID: 12110143 Free PMC article. Review.
-
IL-6 Autoantibodies Predict Lower Platelet Counts and Altered Plasma Cytokine Profiles in Healthy Blood Donors: Results From the Danish Blood Donor Study.Front Med (Lausanne). 2022 Jun 24;9:914262. doi: 10.3389/fmed.2022.914262. eCollection 2022. Front Med (Lausanne). 2022. PMID: 35814772 Free PMC article.
-
Detection of IL-6 and its receptor mRNAs in a megakaryocytic cell line, CMK, by an RT-nested PCR.Ann Hematol. 1994 Nov;69(5):245-7. doi: 10.1007/BF01700278. Ann Hematol. 1994. PMID: 7948313
-
Gfi1b controls integrin signaling-dependent cytoskeleton dynamics and organization in megakaryocytes.Haematologica. 2017 Mar;102(3):484-497. doi: 10.3324/haematol.2016.150375. Epub 2017 Jan 12. Haematologica. 2017. PMID: 28082345 Free PMC article.
-
Interleukin-6 in Rheumatoid Arthritis.Int J Mol Sci. 2020 Jul 23;21(15):5238. doi: 10.3390/ijms21155238. Int J Mol Sci. 2020. PMID: 32718086 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical